L.V. Anderson
Neurobiology Department
University Medical School
Newcastle upon Tyne
United Kingdom
Name/email consistency: high
- Secondary reduction in calpain 3 expression in patients with limb girdle muscular dystrophy type 2B and Miyoshi myopathy (primary dysferlinopathies). Anderson, L.V., Harrison, R.M., Pogue, R., Vafiadaki, E., Pollitt, C., Davison, K., Moss, J.A., Keers, S., Pyle, A., Shaw, P.J., Mahjneh, I., Argov, Z., Greenberg, C.R., Wrogemann, K., Bertorini, T., Goebel, H.H., Beckmann, J.S., Bashir, R., Bushby, K.M. Neuromuscul. Disord. (2000)
- Dysferlin is a plasma membrane protein and is expressed early in human development. Anderson, L.V., Davison, K., Moss, J.A., Young, C., Cullen, M.J., Walsh, J., Johnson, M.A., Bashir, R., Britton, S., Keers, S., Argov, Z., Mahjneh, I., Fougerousse, F., Beckmann, J.S., Bushby, K.M. Hum. Mol. Genet. (1999)
- Multiplex Western blotting system for the analysis of muscular dystrophy proteins. Anderson, L.V., Davison, K. Am. J. Pathol. (1999)
- Immunomarkers for molecular mass. Anderson, L.V. Neuromuscul. Disord. (1999)
- Characterization of monoclonal antibodies to calpain 3 and protein expression in muscle from patients with limb-girdle muscular dystrophy type 2A. Anderson, L.V., Davison, K., Moss, J.A., Richard, I., Fardeau, M., Tomé, F.M., Hübner, C., Lasa, A., Colomer, J., Beckmann, J.S. Am. J. Pathol. (1998)
The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.








